Related Experiment Video
Updated: Jul 9, 2026

Performing Behavioral Tasks in Subjects with Intracranial Electrodes
Published on: October 2, 2014
Is an application form useful to select patients with epilepsy who may drive?
Abstract:
Of 1,268 persons who claimed to have epilepsy and were therefore disqualified for military service, 55% had a driving license 5 years later. Only 58% had applied for a driving license. Of those 14% who had answered truthfully the question "have you had fits, epilepsy etc." in the application form, 63% received a license. Fewer persons with epilepsy had a driving license after about 5 years (55%) than did age-matched controls (73%). The application form is of no use in preventing persons with epilepsy from obtaining a driving license. Adequate instruction of the patient and of his physician is to be preferred to the use of an application form.
More Related Videos
05:54Stereo-Electro-Encephalo-Graphy (SEEG) With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
Published on: June 13, 2016
10:23Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
Published on: June 23, 2023
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Epilepsy ll: Types